Incyte (INCY) Total Current Liabilities (2010 - 2026)

Incyte (INCY) reported Total Current Liabilities of $1.5 billion for Q1 2026, down 13.41% on a YoY basis from $1.7 billion in Q1 2025, and down 1.68% quarter-over-quarter from $1.5 billion in Q4 2025.

Incyte (INCY) Total Current Liabilities (2010 - 2026) Analysis & Trends

Incyte has reported Total Current Liabilities for 17 years, with the latest figure at $1.5 billion in Q1 2026.

  • For the quarter ending Q1 2026, Total Current Liabilities fell 13.41% year-over-year to $1.5 billion; the trailing twelve-month figure through Mar 2026 stood at $1.5 billion (down 13.41% YoY), and the FY2025 full-year result was $1.5 billion, down 7.72% from the prior year.
  • Total Current Liabilities for Q1 2026 stood at $1.5 billion, down from $1.5 billion in the prior quarter.
  • The five-year high for Total Current Liabilities was $1.7 billion in Q1 2025, with the low at $886.2 million in Q1 2022.
  • Historically, Total Current Liabilities has averaged $1.3 billion across 5 years, with a median of $1.3 billion in 2025.
  • Annual changes were most pronounced in 2022 — Total Current Liabilities jumped 42.04% — and 2026, when it slipped 13.41%.
  • Incyte's Total Current Liabilities stood at $1.2 billion in 2022, then gained by 7.2% to $1.2 billion in 2023, then soared by 32.37% to $1.6 billion in 2024, then fell by 7.72% to $1.5 billion in 2025, then declined by 1.68% to $1.5 billion in 2026.
  • The last three Total Current Liabilities figures came in at $1.5 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.70 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 16.35 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 636.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 13.42 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 3.88 Bn
9 Abivax 91.96 Bn 91.96 Bn - 72.86 Mn
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn 1.49 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.49 Bn
Dec 31, 2025 1.52 Bn
Sep 30, 2025 1.34 Bn
Jun 30, 2025 1.28 Bn
Mar 31, 2025 1.72 Bn
Dec 31, 2024 1.64 Bn
Sep 30, 2024 1.50 Bn
Jun 30, 2024 1.34 Bn
Mar 31, 2024 1.40 Bn
Dec 31, 2023 1.24 Bn
Sep 30, 2023 1.12 Bn
Jun 30, 2023 1.12 Bn
Mar 31, 2023 1.01 Bn
Dec 31, 2022 1.16 Bn
Sep 30, 2022 1.01 Bn
Jun 30, 2022 926.67 Mn
Mar 31, 2022 886.16 Mn
Dec 31, 2021 854.31 Mn
Sep 30, 2021 742.71 Mn
Jun 30, 2021 660.32 Mn